Idelalisib D5
| Product Name | Idelalisib D5 |
|---|---|
| Alternate Names | Idelalisib Stable Isotopes, Stable Isotopes of Idelalisib |
| CAT No. | CS-O-15736 |
| CAS No. | 1830330-31-8 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 420.45 g/mol |
| Mol. For. | C₂₂H₁₃D₅FN₇O |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Idelalisib |
| Purity | 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | CC[C@@H](C(N1C(C([2H])=C2[2H])=C(C([2H])=C2[2H])[2H])=NC3=CC=CC(F)=C3C1=O)NC4=C(NC=N5)C5=NC=N4 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Idelalisib D5 is a deuterium-labeled form of idelalisib, a phosphoinositide 3-kinase (PI3K) inhibitor that is used in the treatment of certain types of cancers. It is commonly used in the treatment of chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and small lymphocytic lymphoma (SLL).
Idelalisib D5 works by inhibiting the PI3K delta isoform, which is responsible for the growth and survival of B-cells. By inhibiting this enzyme, idelalisib D5 disrupts the signaling pathways that promote cell growth and survival, leading to the death of cancer cells.
Chemically, idelalisib D5 has a molecular formula of C22H15D5N6O3S and a molecular weight of 455.5 g/mol. It is a white to off-white crystalline powder that is sparingly soluble in water and slightly soluble in ethanol. The deuterium labeling of idelalisib D5 serves as a tracer to help researchers better understand the pharmacokinetics and metabolism of the drug in vivo.
Idelalisib D5 is typically administered orally in the form of tablets or capsules, and dosages may vary depending on the type of cancer being treated and the patient's individual health status. While idelalisib D5 has shown promising results in clinical trials, it is important to note that it can cause side effects such as diarrhea, fatigue, and nausea. Patients should always consult with their healthcare provider before beginning treatment with idelalisib D5.
Get an Instant Quote
This page contains information about Idelalisib D5. You can buy Idelalisib D5 from Clearsynth at best competitive price with assured price guarantee. Clearsynth offers best quality Idelalisib D5